Log in

2566 Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. HKEX · China

Hangzhou Jiuyuan Genetic Biopharmaceutical Co. (2566) news

Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2566, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Hangzhou Jiuyuan Genetic Biopharmaceutical Co. news

We have not published a story on Hangzhou Jiuyuan Genetic Biopharmaceutical Co. yet. When there is news, it will appear here.

Questions about Hangzhou Jiuyuan Genetic Biopharmaceutical Co.

What is the ticker symbol of Hangzhou Jiuyuan Genetic Biopharmaceutical Co.?

Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. trades under the ticker 2566 on HKEX.

Where is Hangzhou Jiuyuan Genetic Biopharmaceutical Co. listed?

Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. is listed on HKEX.

Which country or territory is Hangzhou Jiuyuan Genetic Biopharmaceutical Co. listed under?

Our directory records Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. under China.

What does Hangzhou Jiuyuan Genetic Biopharmaceutical Co. do?

Our directory classifies Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Hangzhou Jiuyuan Genetic Biopharmaceutical Co.?

The ISIN recorded for Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. is CNE100006KF0.

Does aibio.space cover Hangzhou Jiuyuan Genetic Biopharmaceutical Co.?

aibio.space lists Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Hangzhou Jiuyuan Genetic Biopharmaceutical Co.?

Companies in our directory listed in the same country and business area as Hangzhou Jiuyuan Genetic Biopharmaceutical Co.: Guangdong Lifestrong Pharmacy Co., Yabao Pharmaceutical Group Co., Zhejiang East Asia Pharmaceutical Co., KPC Pharmaceuticals, Shenyang Xingqi Pharmaceutical Co., ImmuneOnco Biopharmaceuticals (Shanghai).

Investor discussion: Hangzhou Jiuyuan Genetic Biopharmaceutical Co.

Members talk about Hangzhou Jiuyuan Genetic Biopharmaceutical Co. (2566). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Hangzhou Jiuyuan Genetic Biopharmaceutical Co., newest first. Each line links the filing it comes from.

  1. Financings

    Share or debt issue: CIRCULAR FOR THE ANNUAL GENERAL MEETING OF 2025. Source

  2. Financings

    Share or debt issue: CIRCULAR FOR THE ANNUAL GENERAL MEETING OF 2024. Source

  3. Financings

    Share or debt issue: GLOBAL OFFERING. Source

Press releases

Headlines of Hangzhou Jiuyuan Genetic Biopharmaceutical Co.'s own announcements, newest first. Each opens the full release on the newswire that carried it.

  1. HKEXnews

    ARTICLES OF ASSOCIATION

  2. HKEXnews

    POLL RESULTS OF THE FIRST EXTRAORDINARY GENERAL MEETING OF 2026 HELD ON FRIDAY, SEPTEMBER 18, 2026

  3. HKEXnews

    NOTICE OF THE EXTRAORDINARY GENERAL MEETING

  4. HKEXnews

    (1) PROPOSED CHANGES IN USE OF PROCEEDS; (2) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION; AND (3) NOTICE OF THE EXTRAORDINARY GENERAL MEETING

  5. HKEXnews

    RENEWAL OF EXISTING CONTINUING CONNECTED TRANSACTIONS

  6. HKEXnews

    VOLUNTARY ANNOUNCEMENT REPURCHASE OF H SHARES BY THE COMPANY UNDER THE REPURCHASE MANDATE

  7. HKEXnews

    (I) PROPOSED CHANGES IN USE OF PROCEEDS AND (II) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION

  8. HKEXnews

    INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026

  9. HKEXnews

    TERMS OF REFERENCE OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS

  10. HKEXnews

    (UPDATED) Final Dividend for the Year Ended 31 December 2025

  11. HKEXnews

    (1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 15, 2026; (2) APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR; (3) AMENDMENTS TO THE ARTICLES OF ASSOCIATION; (4) ABOLISHMENT OF THE SUPERVISORY COMMITTEE; (5) APPOINTMENT OF EMPLOYEE REPRESENTATIVE DIRECTOR; AND (6) FINAL DIVIDEND

  12. HKEXnews

    RESTORATION OF PUBLIC FLOAT

  13. HKEXnews

    INSIDE INFORMATION COMPLETION OF THE H SHARE FULL CIRCULATION

  14. HKEXnews

    CHANGE OF COMPANY NAME

  15. HKEXnews

    INSIDE INFORMATION GRANT OF LISTING APPROVAL BY THE STOCK EXCHANGE FOR IMPLEMENTATION OF THE H SHARE FULL CIRCULATION

  16. HKEXnews

    MONTHLY UPDATE ANNOUNCEMENT IN RELATION TO PUBLIC FLOAT

  17. HKEXnews

    VOLUNTARY ANNOUNCEMENT - JY54 INJECTION OBTAINED CLINICAL TRIAL APPROVAL IN CHINA

  18. HKEXnews

    NOTICE OF THE ANNUAL GENERAL MEETING

  19. HKEXnews

    CIRCULAR FOR THE ANNUAL GENERAL MEETING OF 2025

  20. HKEXnews

    INSIDE INFORMATION ISSUANCE OF FILING NOTICE BY THE CSRC FOR THE H SHARE FULL CIRCULATION APPLICATION OF THE COMPANY

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:2566 on TradingView.

Listing details

Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2566, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.
Ticker
2566
Listing
HKEX
Country or territory
China
Business scope
Pharmaceuticals: Major
ISIN
CNE100006KF0
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.